title: 4-(1,2-Benzisothiazol-3-yl)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities.
abstract: Continuing their studies on benzisothiazolyl derivatives, Authors refer to the preparation and pharmacological properties of 4-(1,2-benzisothiazol-3-yl) alkanoic and phenylalkanoic acids. All substances were tested for anti-inflammatory, analgesic and antipyretic properties. As reference compounds, 1,2-benzisothiazolin-3-one and 4-(3-oxo-1,2-benzisothiazolin-3-yl) phenylacetic acid, as prototypes of benzisothiazolinonic derivation. Ibuprofen, as a prototype of substituted arylalkanoic acids, and Phenylbutazone were used. Analysis of the data leaded to the following conclusions. Introduction of the aryl moiety, passing from benzisothiazolylalkanoic to benzisothiazolyl-phenylalkanoic structures, produced a remarkable increase of activity. 2-[4-(1,2-benzisothiazol-3-yl)phenyl] propionic and 2-[4-(1,2-benzisothiazol-3-yl)phenyl]butyiric acids showed anti-inflammatory, analgesic and antipyretic properties comparable to those of Ibuprofen. Substantial differences in variations in activities were observed comparing the properties of benzisothiazolylphenylalcanoic acids with those of the benzisothiazolinonic series, object of preceding studies.
authors.affiliation: Istituto di Chimica Farmaceutica e Tossicologica, Facoltà di Farmacia, Università di Parma.
authors.forename: F
authors.initials: F
authors.lastname: Bordi
authors.forename: M
authors.initials: M
authors.lastname: Mor
authors.forename: P V
authors.initials: PV
authors.lastname: Plazzi
authors.forename: C
authors.initials: C
authors.lastname: Silva
authors.forename: G
authors.initials: G
authors.lastname: Morini
authors.forename: M
authors.initials: M
authors.lastname: Impicciatore
authors.forename: E
authors.initials: E
authors.lastname: Barocelli
authors.forename: M
authors.initials: M
authors.lastname: Chiavarini
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000138:chemical synthesis* / Q000494:pharmacology; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control; D004926:Escherichia coli; D007052:Ibuprofen / Q000494:pharmacology; D008297:Male; D051379:Mice; D010146:Pain / Q000139:chemically induced / Q000188:drug therapy; D010653:Phenylbutazone / Q000494:pharmacology; D011749:Pyrogens / Q000037:antagonists & inhibitors; D051381:Rats; D017208:Rats, Wistar; D013844:Thiazoles / Q000138:chemical synthesis* / Q000494:pharmacology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D011749:Pyrogens; D013844:Thiazoles; D002351:Carrageenan; D010653:Phenylbutazone; D007052:Ibuprofen